Festi hf.'s acquisition of the entire share capital of Lyfja hf. is completed and the company has thereby become part of the Festi Group.
The reference closing date for the acquisition is July 1, 2024, and Lyfja will therefore be included in Festi's consolidated financial statements as of that date.
The purchase price for the acquisition amounted to ISK. 7,116 million, based on the company's preliminary financial statements, which is divided into a cash payment in the amount of ISK 5,076 million and the delivery of 10 million shares in Festi with a market value of ISK 2,040 million based on the closing price of 204 on Nasdaq Iceland on July 10, 2024, respectively.
Today, Festi took out a new loan for the acquisition, which will increase the Group's leverage by ISK 4,000 million. Further details about the transaction and its financing will be provided in connection with the publication of the Company's 2nd quarter results on July 31.
Concurrently with today's completion of the acquisition, Hildur Þórisdóttir, acting CEO and managing director of Lyfja's human resources department, has joined Festi's executive management.
Ásta S. Fjeldsted, CEO of Festi:
"This is a major moment and an important milestone on Festi's journey. The finalisation of the merger has taken some time, but this has been a learning process that lays a solid foundation for future cooperation within the Group. There are very exciting times ahead and a number of opportunities for cooperation, synergy, increased efficiency and growth across the companies within the Group, which represent some of the strongest brands in Iceland in their respective markets. Lyfja possesses highly trained and well-educated staff who have built one of the largest drug store chains in Iceland. Aided by a united, experienced and talented team of employees, we will provide consumers and businesses in Iceland with a wide but targeted selection of essential products at the best prices. App and online sales, along with our well-located service centers and stores throughout Iceland, will play a key role in this effort. At the same time, emphasis will be placed on promoting improved public health in Iceland through quality products, education, consultancy and other health services as opportunities arise. These are all things that that are going to be more and more important, with the increase in the population and rising life expectancy."
For more information, please contact Ásta S. Fjeldsted, CEO of Festi – asta@festi.is
Let me know how I can help George!